A Form 4 filed on September 8, 2026, reports that Frank G. Pellegrino, a director of Citizens & Northern Corp (NASDAQ:CZNC), purchased 178 shares of common stock on September 4, 2026, under a pre-established written trading plan.
A Form 4 filed on September 8, 2026 with the U.S. Securities and Exchange Commission disclosed that Perry G. Hines, a director at Horace Mann Educators Corp /DE/ (NYSE:HMN), sold 3,237 shares of common stock on September 3, 2026.
Donald M. Carley, General Counsel of Horace Mann Educators Corp /DE/, filed a Form 4 on September 8, 2026, disclosing the sale of 2,054 shares of common stock on September 3, 2026.
Director Nina C. Grooms filed a Form 4 with the SEC on September 8, 2026, reporting a gift transaction in Alamo Group Inc. common stock dated September 3, 2026.
A Form 4 filed on September 8, 2026, discloses that Erez Shachar, a director of Riskified Ltd. (NYSE:RSKD), sold 50,000 Class A Ordinary Shares on September 3, 2026, at a weighted average price of $6.7202 per share.
Eido Gal, Chief Executive Officer and Director of Riskified Ltd. (NASDAQ:RSKD), filed a Form 4 on September 8, 2026, disclosing the sale of 150,000 Class A Ordinary Shares on September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed on September 8, 2026, discloses that John Cox, CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), disposed of 5,658 shares of common stock on September 8, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units.
Douglas Kerr, Chief Medical Officer of Dyne Therapeutics, Inc., filed a Form 4 on September 8, 2026, reporting two automatic sales of common stock on September 4 and September 8, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units.
Johanna Friedl-Naderer, Chief Commercial Officer of Dyne Therapeutics, Inc. (NASDAQ:DYN), filed a Form 4 on September 8, 2026, disclosing two automatic sales of common stock on September 4 and September 8, 2026, both executed to satisfy tax withholding obligations upon the vesting of restricted …
A Form 4 filed on September 8, 2026, discloses that Dean Everett Erstad, Senior VP of Sales and Marketing at Seneca Foods Corp (NASDAQ:SENEA), sold 1,587 shares of Seneca Foods Class A Common Stock on September 4, 2026.